By staff writers

July 28, 2016 -- Canadian microultrasound technology developer Exact Imaging is highlighting initial clinical results published in the Journal of Urology for its prostate risk identification microultrasound (PRI-MUS) protocol with its ExactVu platform.

The study, led by Dr. Sangeet Ghai at Princess Margaret Cancer Centre in Toronto, found that the protocol helped detect significant disease using microultrasound for real-time visualization of suspicious lesions and to guide biopsies (J Urol, August 2016, Vol. 196:2, pp. 562-569).

Exact Imaging plans to seek CE Mark approval and clearance from the U.S. Food and Drug Administration (FDA) for ExactVu in the coming months, the company said.

Copyright © 2016

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking